cancer of primary unknown
Conditions
Interventions
Chemotherapy
Sponsors
Department of Medical Oncology, Kinki University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The eligibility criteria are as follows;(1) histologic or cytologic confirmation of metastatic cancer with unknown primary site (2) not subject to radiation or surgery(3) measurable or evaluable lesions; (4) no previous treatments (5) Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2 (6)age more than 20 (7) adequate organ function (8) written informed consent
Exclusion criteria
Exclusion criteria: The exclusion criteria are as follows: 1.female adenocarcinoma with axillary lymph nodes swelling only, or pelvic cavity endolymph nodes only 2.squamous carcinoma with cervical lymph nodes swelling only, or inguen lymph nodes only 3.patients with germ cell tumor or have characteristic of neuroendocrine tumor 4.patients with high level of PSA in serum or tumor (1) severe infection or other severe complications (such as gastrointestinal bleeding, heart disease) (2) symptomatic brain metastasis (3) patients who carried out bone marrow transplantation (4) patients who carried out peripheral blood stem cell transplantation (5) drug allergy (6) pregnancy or lactating (7) male patients who hope for pregnancy (8) uncontrollable diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response Rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety Profile | — |
Countries
Japan
Contacts
Public ContactTakayasu Kurata
Kinki University School of Medicine Department of Medical Oncology
Outcome results
None listed